Translational research is now at the forefront of most researchers minds. It has never been more crucial for R&D companies and for the benefit of society, to shorten the time to market for new drug and healthcare technologies.
ON Helix is a one day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).
It presents the UK landscape of the business environment, funding, scientific and clinical research excellence and will be a unique knowledge-sharing environment between academia and business:
We are delighted to announce our Keynote Speakers:
Sharon Vosmek, CEO, Astia
David Tapolczay, CEO, MRC Technology
Sara-Jane Dunn, Microsoft
Click to view our 2017 programme for ON Helix.
The conference will commence with our Welcome Reception and Summer BioNewsRound Award on 12 July, more information can be found here.
To register, please click here.